# Prospect Capital Corp: overview PSEC · Nasdaq · CIK 1287032 · [Other](/sectors/other.md) · fiscal year ends Jun 30 Pages: [Overview](/companies/psec.md) · [Financials](/companies/psec/financials.md) · [Filings](/companies/psec/filings.md) · [Insiders](/companies/psec/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [(0.38)](/filings/0001287032-25-000339.md) | [(0.07)](/filings/0001287032-26-000045.md) | [(0.39)](/filings/0001287032-26-000164.md) | not reported | [0.08](/filings/0001287032-25-000339.md) | [(0.01)](/filings/0001287032-26-000045.md) | [0.05](/filings/0001287032-26-000164.md) | not reported | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2024 (2024-06-30) | FY (2024-08-31) | FY2025 (2025-06-30) | FY (2025-08-31) | FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.34](/filings/0001287032-26-000269.md) | not reported | [(1.35)](/filings/0001287032-26-000269.md) | not reported | [0.06](/filings/0001287032-26-000269.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/psec/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [PRIVATE MANAGEMENT GROUP INC](/funds/1142031.md) | 2026-06-30 | $47.4m | 20,534,804 | | Added +6,999,513 | | [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $32.5m | 14,082,619 | | Reduced −1,766,788 | | [VAN ECK ASSOCIATES CORP](/funds/869178.md) | 2026-06-30 | $22.4m | 9,685,724 | | Added +2,388,990 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $15.3m | 6,633,748 | | Added +1,160,380 | | [Legal & General Group Plc](/funds/764068.md) | 2026-06-30 | $9.3m | 4,032,811 | | Added +392,146 | | [GENDELL JEFFREY L](/funds/1056581.md) | 2026-06-30 | $9.3m | 4,009,902 | | Unchanged | | [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $7.1m | 3,067,650 | | Reduced −1,683,570 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $6.2m | 2,686,736 | | Added +234,820 | | [INDEPENDENT FINANCIAL GROUP, LLC](/funds/275484.md) | 2026-06-30 | $5.7m | 2,485,356 | | Reduced −974,995 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $5.3m | 2,295,500 | Put | Added +829,700 | ## Recent filings [All 3,234 filings](/companies/psec/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-27 | 16:18 ET | [8-K](/filings/0001287032-26-000296.md) | 2.02 Results of operations | 0001287032-26-000296 | | 2026-10-20 | 17:07 ET | [SCHEDULE 13D/A](/filings/0001294357-26-000016.md) | Ownership report, active investor, amended | 0001294357-26-000016 | | 2026-09-22 | 16:06 ET | [DEF 14A](/filings/0001287032-26-000288.md) | Proxy statement, period 2026-09-22 | 0001287032-26-000288 | | 2026-08-21 | 17:33 ET | [8-K](/filings/0001287032-26-000270.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001287032-26-000270 | | 2026-08-20 | 17:31 ET | [10-K](/filings/0001287032-26-000269.md) | Annual report, period 2026-06-30 | 0001287032-26-000269 | | 2026-07-07 | 17:13 ET | [8-K](/filings/0001287032-26-000224.md) | 5.07 Shareholder vote results | 0001287032-26-000224 | | 2026-05-21 | 21:29 ET | [SCHEDULE 13D/A](/filings/0001294357-26-000002.md) | Ownership report, active investor, amended | 0001294357-26-000002 | | 2026-05-08 | 16:04 ET | [8-K](/filings/0001287032-26-000174.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001287032-26-000174 | | 2026-05-07 | 17:00 ET | [8-K](/filings/0001287032-26-000165.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001287032-26-000165 | | 2026-05-07 | 16:45 ET | [10-Q](/filings/0001287032-26-000164.md) | Quarterly report, period 2026-03-31 | 0001287032-26-000164 | ## Latest annual report [Form 10-K for the fiscal year ended Jun 30, 2026](/filings/0001287032-26-000269.md), filed Aug 20, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1287032 - Tickers: PSEC, PSEC-PA - Exchange: Nasdaq - SIC code: not reported - State of incorporation: MD - Filer category: Large accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 09:51 ET. No prices; not investment advice.